Friday 6 November 2026 Export EW’s income statement to Excel — free account

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.

Revenue: +10.5%
EPS: +6.00%
Free cash flow: −1.84%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

101.66 0.84 +0.83%

Follow EW

Alert me

Market cap: $58.1B
P/E: 56.7×
Fwd P/E: 36.5×
Dividend yield: —
F-score: 5/9
Altman Z: 11.54
Beneish M: −2.48
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Edwards Lifesciences Corporation (EW) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Edwards Lifesciences Corporation (EW) trades at a P/B ratio of 5.3×. Over the past ten years it has ranged from 3.9× (April 2025) to 14.9× (September 2021); the current reading is higher than 18% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/EW/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Edwards Lifesciences Corporation P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/EW/metrics/pb-ratio">Edwards Lifesciences Corporation (EW) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	4.8×	9.68%
FY2024	4.4×	(35.56%)
FY2023	6.8×	(13.82%)
FY2022	7.9×	(42.78%)
FY2021	13.8×	11.43%
FY2020	12.4×	6.02%
FY2019	11.7×	14.78%
FY2018	10.2×	28.20%
FY2017	8.0×	2.46%
FY2016	7.8×	14.23%

Period	P/B ratio	Change
Sep 2026	4.5×	(6.65%)
Jun 2026	4.9×	8.25%
Mar 2026	4.5×	(6.87%)
Dec 2025	4.8×	8.23%
43 more quarters	Free account

Against its own ten years

Low 3.9× High 14.9×

Ten-year median 8.4×

Current reading's percentile 20

Company	P/B ratio
ZBH Zimmer Biomet Holdings, Inc. compare	1.6×
PHG Koninklijke Philips N.V. compare	2.2×
BSX Boston Scientific Corporation compare	2.5×
MDT Medtronic PLC compare	2.6×
GEHC GE HealthCare Technologies Inc. compare	3.2×
STE STERIS plc compare	3.4×
EW Edwards Lifesciences Corporation	5.3×
SYK Stryker Corporation compare	5.4×
DXCM DexCom, Inc. compare	12.5×
Medical Devices industry median	2.5×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Edwards Lifesciences Corporation (EW) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on EW

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on EW

Stockrow Weekly